Projects & Initiatives

One of the most exciting and beneficial elements of WECAN is the potential for true collaboration across the European cancer community.

WECAN provides a platform for coordination and collaboration. We enable long-term benefits for the cancer patient community and stakeholders through shared goals, learning, and development.

Ongoing projects & Initatives

WECAN Academy

Educational programmes for patient advocates and patient organisations.

LEARN MORE

Reasonable agreements between patient advocates and pharmaceutical industry

Collaboration with 35 patient organisations, 16 pharmaceutical companies and 7 other project partners to make the legal relationship between patient advocates and pharmaceutical companies easier and more acceptable

DOWNLOAD THE GUIDELINES

Setting International Standards in the Analysis Quality of Life data

WECAN, represented by Myeloma Patient Europe (MPE), ensures that the patient’s perspective is taken into account in the recommendations, and that a lay version of the recommendations will be available for the wider public.

VISIT SISAQOL IMI

Global Principles for remunerating the patient community for interactions with the pharmaceutical industry

PFMD and contributors are driving a comprehensive co-creation effort to establish a trusted process to remunerate the patient community. WECAN, represented by Myeloma Patient Europe (MPE), ensures that the patient’s perspective is taken into account.

DOWNLOAD THE PRINCIPLES

COVID-19

The COVID-19 epidemic is of concern to many cancer patients. Many of the European cancer patient organisations are providing information about COVID-19 and specific recommendations to their patient community. See the

 COVID-19 Resources of WECAN members

Past Projects

Survey on Fair Market Value

Compensation for the work of patient advocates at Fair Market Value

Results of the WECAN Survey on Fair Market Value

(6 March 2019)

EU integration of Health Technology Assessment

WECAN position on further EU integration of Health Technology Assessment (HTA)

Position Paper, 22 June 2018